Trials / Completed
CompletedNCT01723267
Automated 3D (SonoAVC) Versus 2D Ovarian Follicles Assessment in IVF Cycles: a Randomized Controlled Trial
Automated 3D (SonoAVC) vs 2D Ovarian Follicles Assessment in IVF Cycles: a Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Rabin Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years – 39 Years
- Healthy volunteers
- Not accepted
Summary
Accurate assessment of the size of follicles is important in IVF treatment.Timing of oocyte maturation and subsequent egg collection is largely based on follicle size. An accurate assessment of follicle size and appropriate timing of HCG result in retrieval of more mature oocytes, improved fertilization and higher pregnancy rates. in 3D technology- fter the capturing of a 3D image of an ovary, SonoAVC automatically analyzes the volume dataset, identifies the boundaries of hypoechoic follicles, and provides estimates of their absolute dimensions. These measurements include the largest diameters in three orthogonal planes, the mean follicular diameter (MFD), the volume of the follicle, and the volume-based diameter (d(V)) of the follicle. In the current study the investigators aim to evaluate the use of this automated technique of follicle measurement vs. standard 2D technology on the timing of oocyte maturation and subsequent oocyte retrieval. The investigators speculate that 3D assessment will increase the rate of mature oocyte collection, and eventually will improve other treatment outcomes such as fertilization rate.
Detailed description
Not desired
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 3D follicles assessment | 3D ultrasound evaluation in IVF treatment (vs 2D ultrasound) |
| OTHER | 2D follicles assessment | 2D ultrasound in IVF treatment (vs 3D ultrasound) |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2012-11-07
- Last updated
- 2016-04-12
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01723267. Inclusion in this directory is not an endorsement.